Growth Metrics

BioNTech SE (BNTX) Long-Term Deferred Tax (2020 - 2025)

Historic Long-Term Deferred Tax for BioNTech SE (BNTX) over the last 6 years, with Q3 2025 value amounting to $20.7 million.

  • BioNTech SE's Long-Term Deferred Tax fell 7922.64% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.7 million, marking a year-over-year decrease of 7922.64%. This contributed to the annual value of $87.3 million for FY2024, which is 19.4% down from last year.
  • BioNTech SE's Long-Term Deferred Tax amounted to $20.7 million in Q3 2025, which was down 7922.64% from $88.1 million recorded in Q2 2025.
  • BioNTech SE's 5-year Long-Term Deferred Tax high stood at $346.5 million for Q3 2022, and its period low was $20.7 million during Q3 2025.
  • In the last 5 years, BioNTech SE's Long-Term Deferred Tax had a median value of $104.9 million in 2024 and averaged $156.0 million.
  • Per our database at Business Quant, BioNTech SE's Long-Term Deferred Tax fell by 19.4% in 2024 and then plummeted by 7922.64% in 2025.
  • BioNTech SE's Long-Term Deferred Tax (Quarter) stood at $170.9 million in 2021, then skyrocketed by 37.05% to $234.2 million in 2022, then crashed by 62.66% to $87.5 million in 2023, then fell by 0.19% to $87.3 million in 2024, then tumbled by 76.3% to $20.7 million in 2025.
  • Its Long-Term Deferred Tax stands at $20.7 million for Q3 2025, versus $88.1 million for Q2 2025 and $89.9 million for Q1 2025.